| Guidelines for artificial intelligence in medicine: literature review and content analysis of frameworks NL Crossnohere, M Elsaid, J Paskett, S Bose-Brill, JFP Bridges Journal of Medical Internet Research 24 (8), e36823, 2022 | 82 | 2022 |
| International guidance on the selection of patient-reported outcome measures in clinical trials: a review NL Crossnohere, M Brundage, MJ Calvert, M King, BB Reeve, E Thorner, ... Quality of Life Research 30, 21-40, 2021 | 58 | 2021 |
| Side effects from acute myeloid leukemia treatment: results from a national survey NL Crossnohere, DR Richardson, C Reinhart, B O’Donoghue, SM Love, ... Current medical research and opinion 35 (11), 1965-1970, 2019 | 56 | 2019 |
| Best–worst scaling and the prioritization of objects in health: a systematic review IL Hollin, J Paskett, ALR Schuster, NL Crossnohere, JFP Bridges Pharmacoeconomics 40 (9), 883-899, 2022 | 44 | 2022 |
| Eliciting preferences for HIV prevention technologies: a systematic review SW Beckham, NL Crossnohere, M Gross, JFP Bridges The Patient-Patient-Centered Outcomes Research 14, 151-174, 2021 | 41 | 2021 |
| A framework for promoting diversity, equity, and inclusion in genetics and genomics research TR Rebbeck, JFP Bridges, JW Mack, SW Gray, JM Trent, S George, ... JAMA Health Forum 3 (4), e220603-e220603, 2022 | 39 | 2022 |
| Integrating advance care planning videos into surgical oncologic care: a randomized clinical trial RA Aslakson, SR Isenberg, NL Crossnohere, AM Conca-Cheng, M Moore, ... Journal of palliative medicine 22 (7), 764-772, 2019 | 29 | 2019 |
| A review of paper-based advance care planning aids JFP Bridges, T Lynch, ALR Schuster, NL Crossnohere, KC Smith, ... BMC Palliative Care 17, 1-9, 2018 | 28 | 2018 |
| Age at diagnosis and patient preferences for treatment outcomes in AML: a discrete choice experiment to explore meaningful benefits DR Richardson, NL Crossnohere, J Seo, E Estey, B O'Donoghue, ... Cancer Epidemiology, Biomarkers & Prevention 29 (5), 942-948, 2020 | 27 | 2020 |
| The evolution of patient-focused drug development and Duchenne muscular dystrophy NL Crossnohere, R Fischer, E Crossley, E Vroom, JFP Bridges Expert review of pharmacoeconomics & outcomes research 20 (1), 57-68, 2020 | 27 | 2020 |
| Patient perceptions of diabetes guideline frameworks for individualizing glycemic targets NL Schoenborn, NL Crossnohere, JFP Bridges, CE Pollack, SJ Pilla, ... JAMA internal medicine 179 (12), 1642-1649, 2019 | 23 | 2019 |
| Methods for measuring patient preferences: an update and future directions A Meara, NL Crossnohere, JFP Bridges Current opinion in rheumatology 31 (2), 125-131, 2019 | 23 | 2019 |
| Listening to the patient voice adds value to cancer clinical trials MD Brundage, NL Crossnohere, J O’donnell, S Cruz Rivera, R Wilson, ... Journal of the National Cancer Institute 114 (10), 1323-1332, 2022 | 21 | 2022 |
| Assessing the appropriateness of the EQ-5D for Duchenne muscular dystrophy: a patient-centered study NL Crossnohere, R Fischer, A Lloyd, LA Prosser, JFP Bridges Medical Decision Making 41 (2), 209-221, 2021 | 21 | 2021 |
| The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials C Snyder, N Crossnohere, M King, BB Reeve, A Bottomley, M Calvert, ... Clinical Trials 19 (3), 277-284, 2022 | 20 | 2022 |
| Post-traumatic stress disorder, neighborhood residency and satisfaction, and social network characteristics among underserved women in Baltimore, Maryland KM Jain, M Davey-Rothwell, NL Crossnohere, CA Latkin Women's Health Issues 28 (3), 273-280, 2018 | 19 | 2018 |
| Pretesting discrete-choice experiments: a guide for researchers NB Campoamor, CJ Guerrini, WB Brooks, JFP Bridges, NL Crossnohere The Patient-Patient-Centered Outcomes Research 17 (2), 109-120, 2024 | 18 | 2024 |
| The rise of best-worst scaling for prioritization: a transdisciplinary literature review ALR Schuster, NL Crossnohere, NB Campoamor, IL Hollin, JFP Bridges Journal of choice modelling 50, 100466, 2024 | 18 | 2024 |
| Prioritizing the worries of AML patients: quantifying patient experience using best–worst scaling DR Richardson, AH Oakes, NL Crossnohere, G Rathsmill, C Reinhart, ... Psycho‐Oncology 30 (7), 1104-1111, 2021 | 17 | 2021 |
| How do members of the Duchenne and Becker muscular dystrophy community perceive a discrete-choice experiment incorporating uncertain treatment benefit? An application of … JFP Bridges, JH Tsai, E Janssen, NL Crossnohere, R Fischer, H Peay The Patient-Patient-Centered Outcomes Research 12, 247-257, 2019 | 17 | 2019 |